CYN cygenics limited

stem cells..remember them, page-3

  1. gliontos
    1,302 Posts.
    lightbulb Created with Sketch. 69
    clock Created with Sketch.
    06/06/05
    18:11
    Post #: 936903
    re: stem cells CYN has hit lows of .375

    Seems very undervalued at these levels.

    Currently making just under a million a quarter with revenue rising sharply.

    Anyone have any opinions?

    Intersuise Research report - http://www.cygenics.com/pdf_industryNews/in_1204.pdf

    Valutech commentary -

    CYN - Cygenics Ltd.
    This Singapore biotechnology company moved its headquarters to Melbourne to list on the ASX in June 2004. Since listing, shares have fallen 60%, mainly since November. The market value of the company is $27 million which is reasonable as revenue is increasing significantly and if this continues, fundamentals should support value eventually. (1/6/05)
    CYN Price at posting: 0.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Johns Lyng Group enters scheme implementation deed with PEP
right-arrow Created with Sketch.
CC9 Chariot to Acquire Majority Stake in a Nigerian Lithium Portfolio
right-arrow Created with Sketch.
NEWS Rincon Lithium Project to be powered by 40MW energy infrastructure
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 017 – RBA holds the toppings
right-arrow Created with Sketch.
NEWS Blue Moon first wedge hole intersects 543g/t gold over 1.2m in laminated quartz vein
right-arrow Created with Sketch.
NUZ Positive FDA feedback on NUZ-001 strategy to lift clinical hold
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.